Digestive

WASHINGTON – With increases in consumer spending expected to remain solid during the remainder of the year, the National Retail Federation on Tuesday increased 2016 retail sales projections by 30 basis points to 3.4% over last year.

Online and other non-store sales, which are included in the overall figure, are expected to increase 7% to 10% year-over-year rather than the 6% to 9% percent forecast earlier.

PARSIPPANY, N.J. – While the U.S. OTC market is not highly dynamic in terms of growth, its competitive landscape has changed significantly over the past five years, with the top 10 rankings shifting in 2015, the Kline Group noted on Monday from its recently published Nonprescription Drugs USA.

DUBLIN - Perrigo announced Monday that the U.S. Food and Drug Administration has approved the company's ANDA for omeprazole and sodium bicarbonate capsules, 20mg/1100mg.  This approval will initiate the first store brand launch of an equivalent product to Zegerid OTC capsules.

Shipments to retail customers have already commenced.

Zegerid OTC is indicated for the treatment of frequent heartburn. National brand sales for the twelve months ending June 2016 were $27 million.
 

ALEXANDRIA, Va. - The National Community Pharmacists Association on Tuesday announced its 2016 lineup of one-day seminars to help community pharmacy owners and front-end staff hone their merchandising and marketing skills, as well as a new sponsorship by Good Neighbor Pharmacy and AmerisourceBergen Drug Corporation to continue the Front-End Profit Building Seminars program.

WASHINGTON —  Since the Food and Drug Administration’s March 25, 2014 Part 15 public hearing on the OTC Drug Monograph, the Consumer Healthcare Products Association has been in discussions with FDA and relevant committees in Congress to identify potential enhancements that would update and modernize this regulatory framework for most nonprescription medicines.

STOCKHOLM - Moberg Pharma on Friday announced that the acquisition of three over-the-counter brands from Prestige Brands has been completed as part of a deal worth $40 million.

STOCKHOLM -- Moberg Pharma has signed an agreement to acquire U.S. OTC brands New Skin, Fiber Choice and PediaCare from Prestige Brands, Inc.

The purchase price is $40 million and the acquired brands will be sold through Moberg’s current OTC channel in the U.S, primarily in drugstores such as CVS, Walgreens and Rite Aid and in mass retailers such as Walmart and Target.

Fleet intern Ali Costikyan

Many of those in Fleet Laboratories’ top leadership garnered experience at large consumer packaged goods companies. In fact, the sales leadership team has amassed more than 165 years of experience with eight blue chip companies holding roles across 10 different functions from supply chain to finance. “We have seasoned people who are brand builders,” said Todd Hutsko, VP sales.